Management of iliac occlusions with a new self-expanding endovascular stent  by Raza, Z. et al.
Eur J Vasc Endovasc Surg 15, 439-443 (1998) 
Management of Iliac Occlusions with a New Self-expanding 
Endovascular Stent 
Z. Raza*, J. W. Shaw% P. A. Stonebridge and P. 3". McCollum 
Departments of Vascular Surgery and ~Clinical Radiology, Ninewells Hospital and Medical School, 
Dundee DD1 9SY, U.K. 
Objectives: To determine the patency and acceptability of the Memotherm endovascular stent in the treatment of iliac 
arterial occlusions. 
Materials and methods: Twenty-two patients (12 males and 10 females) underwent stenting of iliac occlusions of the 
aortoiliac bifi~rcation, the common iliac artery and the external iliac artery. All patients were reassessed at 3, 6 and 12 
month intervals and then yearly to evaluate their symptoms and Doppler pressure measurements. Comparison was made 
with results from other studies treating iliac occlusions by angioplasty alone or combined with stenting. 
Results: Out of 22 patients, 21 had an immediate and sustained mprovement over the whole of the follow-up period. 
The Ankle-brachial Index (ABI) increased from a mean value of 0.49 to 0.81 3-months postprocedure and improved to 
0.85 at 12 months (paired t-test p<O.O01). At 6 and 12 months the stent patency remained at 95.5%, which compares 
favourably with other studies. There were four minor and one major complication associated with the stenting procedure. 
Conclusions: The Memotherm self-expanding stent is a us@d, safe and effective device suitable for the majority of iliac 
occlusions. Further long-term evaluation is warranted to confirm its advantages over open surgery. 
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Introduction 
The development of the balloon angioplasty catheter 
by Gruntzig ~allowed percutaneous transluminal n- 
gioplasty (PTA) to develop into an accepted clinical 
treatment modality. Successful guidewire negotiation 
of occlusions with subsequent angioplasty enabled 
many patients to be treated by a technique which has 
a lower morbidity and mortality compared with that 
of bypass surgery. The application of percutaneous 
recannalisation techniques to arterial occlusions re- 
ceived a further boost with the development of in- 
traarterial stenting. 2 Over the past decade, there has 
been an "endovascular explosion" in this field. 3 Until 
recently, only a handful of manufacturers produced 
such stents. Following the success of the Wallstent and 
Palmaz stents, a significant number of new devices 
appeared on the market, each exhibiting individual 
characteristics and advantages. 
In 1994, the Memotherm self-expanding Nitinol stent 
became available on the British market (Bard/An- 
giomed, Crawley, West Sussex, RH11 9BP, England). 
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This is made from nitinol, an alloy of nickel and 
titanium which has the special property of thermal 
memory. Individual stents are produced to a specific 
diameter which becomes incorporated as thermal 
memory during the manufacturing process. On cooling 
to the temperature of ice this memory is lost, allowing 
the stent to be compressed and loaded onto a small 
coaxial catheter delivery system (Fig. 1). Once the 
Fig. 1. The Memotherm stent during itscompressed and loaded 
state. Upon release, the stent expands toits original diameter. 
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Fig. 2. Stent deployment with the pistol-like trigger action. 
stent is released in the intravascular compartment and 
exposed to body temperature, it immediately regains 
its thermal memory and self-expands to the original 
diameter. The result of this technology is a flexible 
self-expanding stent which conforms to the natural 
geometry of the vessel within which it is deployed. 
The delivery system passes through a 6- or 7-French 
introducer sheath, compared to the 9F system of earlier 
stents, causing less risk of puncture site complications 
such as groin haematoma. Stent deployment is effected 
by a repeated trigger action on a simple pistoMike 
handle at the proximal end of the delivery catheter 
(Fig. 2). Iliac stents are available in lengths from 
20-110 mm at 10 mm increments and in fully expanded 
diameters of 7, 8, 9, 10 and 12 mm. It is recommended 
that stent dimensions are chosen such that the fully 
expanded diameter is i mm greater than the PTA 
dilatation balloon and that the stent overlaps the oc- 
cluded segment by at least 10 mm at either end. The 
flexibility and thermal sensitivity of the stent has 
allowed its use to be extended to the treatment of 
malignant biliary obstruction, 4 although initial ex- 
perience with the device in benign prostatic hy- 
perplasia has not been a major success, necessitating 
further modifications. 5 We report a series of 22 patients 
with iliac arterial occlusions who were treated with 
the Memotherm self-expanding nitinol stent. 
Materials and Methods 
During the period June 1994 to December 1995, 27 
consecutive patients with iliac occlusions were con- 
sidered for stenting. There were 15 males and 12 
females, with a mean age of 61 years (range 45-87). 
Seventy per cent of the patients were active smokers. 
Guidewire recannalisation of the occluded segment 
was unsuccessful in two cases. Of the remaining 25, 
three had Palmaz stents inserted and 22 had Me- 
motherm stents. In this group of 22 treated with the 
Memotherm, 18 patients had claudication, with six 
patients in Fontaine stage IIa and 12 patients with 
disabling claudication in Fontaine stage IIb. The re- 
maining four patients had rest pain satisfying the 
criteria for critical limb ischaemia. 6 Three types of 
iliac occlusions were identified. Seven patients had 
occlusions not involving the common iliac origin, there 
being at least 10 mm of patient proximal common iliac 
artery, thus allowing a unilateral stenting procedure. 
A second group of 11 patients had occlusions which 
involved the common iliac origin, necessitating a bi- 
lateral kissing stent procedure. This is required because 
a single stent usage for a common iliac artery occlusion 
would have to be placed precisely at the common iliac 
origin, otherwise haemodynamic turbulence would be 
created which could lead to future stenosis7 Even 
using balloon expandable stents, it is not possible to 
guarantee precise placement of this nature. Such a 
kissing stent procedure provides structural stability, 
which prevents emboli and plaques ofatheroma being 
displaced own the contralateral common iliac artery. 
Similarly, haemodynamic stability resuls in a smooth 
blood-flow situation, resulting in no restenosis due to 
turbulence, which would otherwise be caused by one 
stent protruding out of the common iliac artery origin. 
Only flexible stents are suitable for this procedure. Of 
the 11 contralateral common iliac arteries, five were 
healthy and six were affected by significant stenotic 
disease. The third group of four patients had external 
iliac artery occlusions. 
All stenting procedures were performed by the same 
operator (JWS). Following Seldinger catheterisation f 
the common femoral artery in the groin, a 7F arterial 
sheath was introduced. The occluded segment of the 
artery was initially recannalised with a guidewire. In 
the majority of cases an angled Terumo guidewire was 
used but occasionally a straight flexible tip guidewire 
was used. The stent delivery system was then passed 
through the sheath and positioned within the oc- 
clusion. The average length of an occlusion was 45 mm 
(range 10-180 mm). Following deployment ofthe stent, 
balloon angioplasty was performed. A full description 
of the stent deployment teclznique is described else- 
where by one of the authors,  The technique of primary 
stent placement before balloon dilatation was con- 
sidered essential to reduce the risk of distal embolic 
phenomena. For the purpose of statistical analysis, 
bilateral (kissing) stents deployed at the aortic bi- 
furcation were considered as two individual stent 
placements within a single patient reatment episode. 
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All patients received an intra-arterial bolus of 3000 
units of Heparin during the procedure. Subcutaneous 
Heparin was continued for 24 h afterwards (5000 units 
b.d.). Anti-platelet herapy, in the form of Aspirin 
150 mg daily, was commenced at least 24 h before the 
procedure and continued indefinitely. The median 
patient follow-up was 15 months (range 8 months-25 
months, mean 12 months). Assessment was based on 
improvement of clinical symptoms according to the 
Fontaine classification 9 as well as the ankle brachial 
index (ABI). All patients were followed-up ost stent 
insertion at 3 months, 6 months, 12 months and an- 
nually thereafter. 
Results 
Of the 27 patients considered for endovascular t eat- 
ment of iliac occlusions, the recannalisation procedure 
was successful in 25, i.e. 92.6% primary technical suc- 
cess. In the 22 patients treated with the Memotherm, 
stent deployment was technically successful in all 
cases, which was defined as the restoration of a func- 
tionally patent lumen with a maximum stenosis of 
30%. Overall procedure complications occurred in five 
patients. Four suffered a minor groin haematoma, not 
requiring surgical intervention. One patient suffered 
a post-procedure thrombosis distal to the stented site. 
This occurred in an external iliac artery distal to a 
common iliac stent replacement and was successfully 
treated by surgical bypass. There were no cases of 
clinically apparent distal embolisation. A single stent 
sufficed for each target lesion in all but one case, a 
combined common il iac/external iliac occlusion meas- 
uring 8 cm long and treated by two overlapping stents. 
The mean fluoroscopy time was 11.7min (range 
3.2-25.4 min). The average stent length was 65 mm 
(range 15-110 ram). 
There was an immediate clinical improvement in 21 
of the 22 by at least one Fontaine class. The one patient 
who failed to improve, mentioned earlier, sustained a
thrombosis of the external i iac artery following a more 
proximal stent insertion into the common iliac artery. 
The patient subsequently underwent a successful i io- 
profunda bypass procedure at a later date. At oper- 
ation, the stent was not removed from the common 
iliac artery. No particular difficulty was encountered 
when the vessel was clamped during the bypass pro- 
cedure, as clamps were placed at a remote position 
from that of the stented portion. The mean ABI im- 
proved from a baseline (_  S.D.) of 0.49 + 0.21 to 
0.81 + 0.24 at 3 months (paired samples t-test, t= 8.52, 
20d.f., p<0.001). At 12 months the mean ABI was 
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Fig. 3. A plot of the ankle brachial index (ABI) of all the patients 
undergoing Memotherm stent insertion for the treatment of iliac 
occlusion pre- and post-stenting. Error bars show one standard 
deviation from the mean. 
0.85+_0.19 (Fig. 3) with all patients report ing an 
improvement of at least one Fontaine class. This im- 
provement was sustained over the whole of their 
follow-up period. The stent was considered patent if 
the patients had no deterioration i their claudication 
distance, had a palpable femoral pulse and their ABI 
remained stable. 
Intra-arterial pressure measurements were not per- 
formed. Follow-up angiography was carried out in 11 
of the patients who had bilateral "kissing" stents. Two 
patients had a 25% stenosis post-stenting at11 months' 
and 13 months' follow-up. This was not considered to 
be haemodynamical ly significant. The area of stenosis 
in one patient was within the stented portion of the 
vessel and in the other patient occurred at the distal 
end of the stent. Both stenosis occurred at the treated 
portion and not at the kissing segment. The stenosis 
was almost certainly due to intimal hyperplasia but 
angioscopy was not performed in any of these affected 
patients. 
Discussion 
To be clinically attractive, any new stent should offer 
considerable advantages over existing products. In 
our series of 22 patients where recannalisation of the 
occlusion was successful, accurate and uncomplicated 
placement of the Memotherm stent was achieved. 
Overall, the recannalisation success rate of this series 
compares favourably with other studies} °-12 The ab- 
sence of significant groin complications can be at- 
tributed to the smaller 7F delivery system. Distal 
embolisation has always been considered to be a sig- 
nificant risk in recannalisation angioplasty of total 
occlusions m12'13 which did not appear to be a problem 
in our present series of patients. Table 1 compares our 
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Table 1. Comparison of results by different authors using endovascular stents or angioplasty alone in the treatment of iliac occlusions. 
No. of Technical Emboli Pre-stenting Post-stenting Stents per Mean 6/12 (%) 
Author Year patients Stent success (%) (%) ABI ABI lesion follow-up Patency 
Current authors 1998 22 Mem 92.6 0 0.49 0.81 1.04" 12 months 95.5 
Vorwerk et al. 1~ 1995 103 Wall 81.0 4.8 0.48 0.89 1.50 29,8 months 92.0 
Vorwerk et al. 19 1990 48 Wall 70.5 2 0.49 0.86 1.44 8,3 months 93.3 
Rees et al. ~1 1989 12 Palmaz 80.0 16 0.54 0.94 1.75 7.4 months 91.7"* 
Colapinto et al. 2° 1981 10 None 80.0 0 0.53 0.82 N/A  8 months 88.0 
* Bilateral "kissing stents" are termed as a single lesion. See text for explanation. 
** Patency at 12 months. 
results to other authors' experience in the treatment 
of iliac occlusions using stents and angioplasty alone. 
The clinical absence of distal embolisation i  our series 
is specifically attributed to the technique of primary 
stent placement before balloon angioplasty, a tech- 
nique also advocated by other authors. 14'I5 The stenting 
of occluded iliac vessels appears to be an excellent 
alternative to aortofemoral or femorofemoral bypass 
surgery in certain patients. However, the long-term 
success of stenting remains to be established. Intimal 
hyperplasia following stent placement remains aprob- 
lem, 16 but successful treatment with balloon an- 
gioplasty has been reported. ~6'~7 Due to its recent 
introduction, follow-up data with the Memotherm 
stent is limited. Its use in the treatment of aortic 
bifurcation disease, including common iliac occlusions, 
has been reported, with no evidence of reocclusion 
over a mean follow-up period of 17 months. ~s 
As for all stenting procedures, there is a learning 
curve during which the operator becomes more con- 
fident and skilled with stent placement. The Me- 
motherm stent has been found to exhibit characteristics 
which make it particularly suitable for the treatment 
of iliac occlusions. In our institute, we have noted a 
small decrease in aortofemoral nd femorofemoral 
crossover graft as a direct result of iliac stenting pro- 
cedures. One of the impacts the stent has had is 
to allow treatment for patients who have disabling 
ischaemia nd pre-existing medical conditions who 
would otherwise be unfit to undergo general an- 
aesthesia due to chronic pulmonary disease and de- 
bilitating cardiac disease. In this situation it would be 
hazardous for a patient undergoing major surgery 
with an accompanying long period of inpatient hos- 
pital stay. 
A further advantage ofthe stent is that most lesions 
are treatable with a single stent. This has financial 
benefits as well as decreased fluoroscopy and pro- 
cedure times. Occlusions longer than 100 mm are likely 
to require two stents, but these can readily be deployed 
overlapping each other. Two stents are also required 
for occlusions involving the common iliac origin where 
the contralateral common iliac artery also needs to be 
stented. In this situation there is no segment of patent 
common iliac origin before the occlusion, and the 
occlusion itself extends right up to the point where 
the aorta bifurcates. This specific requirement at the 
aortic-bifurcation site is common to all stents and it is 
widely accepted that this is the correct procedure for 
such lesions. 7
The Memotherm self-expanding nitinol endo- 
prosthetic stent has been shown to be a safe and 
effective device which is suitable for the majority of 
iliac occlusions. A randomised controlled trial com- 
paring endovascular stenting versus bypass surgery 
is warranted to provide long-term evaluation and 
validity of this technique. 
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